Publication: Clinical Characteristics and Treatment Allocations in Patients with Myelodysplastic Syndromes and Monosomy 7: Results from an International Multicenter Study Suggest That Hypomethylating Agents Significantly Improve Overall-and AML-Free Survival in Patients Classified As Very High Risk By IPSS-R
| dc.bibliographiccitation.issue | 21 | |
| dc.bibliographiccitation.journal | Blood | |
| dc.bibliographiccitation.volume | 124 | |
| dc.contributor.author | Schanz, Julie | |
| dc.contributor.author | Braulke, Friederike | |
| dc.contributor.author | Mufti, Ghulam J. | |
| dc.contributor.author | Crisa, Elena | |
| dc.contributor.author | Kulasekararaj, Austin | |
| dc.contributor.author | Nachtkamp, Kathrin | |
| dc.contributor.author | Germing, Ulrich | |
| dc.contributor.author | Schmitz, Stephan A. | |
| dc.contributor.author | Haas, Peter | |
| dc.contributor.author | Luebbert, Michael | |
| dc.contributor.author | Mueller-Thomas, Catharina | |
| dc.contributor.author | Goetze, Katharina S. | |
| dc.contributor.author | Platzbecker, Uwe | |
| dc.contributor.author | Nolte, Florian | |
| dc.contributor.author | Hofmann, Wolf-Karsten | |
| dc.contributor.author | Haase, Detlef | |
| dc.date.accessioned | 2018-11-07T09:31:27Z | |
| dc.date.available | 2018-11-07T09:31:27Z | |
| dc.date.issued | 2014 | |
| dc.identifier.isi | 000349233801082 | |
| dc.identifier.uri | https://resolver.sub.uni-goettingen.de/purl?gro-2/31537 | |
| dc.notes.status | zu prüfen | |
| dc.notes.submitter | Najko | |
| dc.publisher | Amer Soc Hematology | |
| dc.publisher.place | Washington | |
| dc.relation.conference | 56th Annual Meeting of the American-Society-of-Hematology | |
| dc.relation.eventlocation | San Francisco, CA | |
| dc.relation.issn | 1528-0020 | |
| dc.relation.issn | 0006-4971 | |
| dc.title | Clinical Characteristics and Treatment Allocations in Patients with Myelodysplastic Syndromes and Monosomy 7: Results from an International Multicenter Study Suggest That Hypomethylating Agents Significantly Improve Overall-and AML-Free Survival in Patients Classified As Very High Risk By IPSS-R | |
| dc.type | conference_abstract | |
| dc.type.internalPublication | yes | |
| dc.type.peerReviewed | yes | |
| dc.type.status | published | |
| dspace.entity.type | Publication |